Novavax, Inc. (Nasdaq: NVAX) announced that its strategy for treating avian flu through genetically-engineered virus-like particles (VLPs) was ranked as a Top Ten Innovation at Cleveland Clinic 6th Annual Medical Innovation Summit. Novavax, Inc. believes its vaccine initiatives have the potential to...
Cleveland Clinic Recognizes New Strategies For Creating Vaccines For Avian Flu As A Top Ten Medical Innovation For 2009
Cleveland Clinic Recognizes New Strategies For Creating Vaccines For Avian Flu As A Top Ten Medical Innovation For 2009
Novavax, Inc. (Nasdaq: NVAX) announced that its strategy for treating avian flu through genetically-engineered virus-like particles (VLPs) was ranked as a Top Ten Innovation at Cleveland Clinic 6th Annual Medical Innovation Summit. Novavax, Inc. believes its vaccine initiatives have the potential to...
Protection For People And Pets By Vaccine Based On A Bird Flu Virus
A single vaccine could be used to protect chickens, cats and humans against deadly flu pandemics, according to an article published in the November issue of the Journal of General Virology. The vaccine protects birds and mammals against different flu strains and can even be given to birds while they...
Pitt Scientists Receive $3.6 Million To Test Vaccine Against Deadliest Strain Of Avian Flu
Scientists at the University of Pittsburgh Center for Vaccine Research have been awarded $3.6 million from the National Institutes of Health to conduct animal studies of vaccines designed to protect against the most common and deadliest strain of avian flu, H5N1. Recent outbreaks of H5N1 have prompted...
BMA Cymru Wales Comment On The Death Of Dr Catherine Mullany In Antigua
Chairman of the BMA’s Welsh Council, Dr Tony Calland said: “Dr Mullany was one of our members in Swansea who trained at Imperial College School of Medicine in London and qualified as a doctor in 2002. “We were deeply saddened to learn of Dr Mullany’s untimely death whilst on her...
Indiana Health Officials Examine State’s Pandemic Influenza Ethics Planning
Information relevant to Indiana’s current pandemic influenza preparedness plan was presented July 16 during a symposium convened by the Indiana State Department of Health and the Indiana University Center for Bioethics, “The Ethics of Pandemic Influenza Planning in Indiana: What Have We Done...
Biotech Experts Available To Discuss The Critical Role Of Vaccine Adjuvants In Treating Pandemic Bird Flu
The likelihood of an influenza pandemic caused by an avian influenza (Bird Flu) virus is an increasing concern to the World Health Organization (WHO) and others. Recent breakthroughs on promising cell-based vaccines are encouraging, but manufacturing, stockpiling and distributing enough vaccine to treat...
Confirmed H7N7 Avian Influenza In Oxfordshire Poultry Farm, UK
Following confirmation of the avian influenza virus subtype as H7N7, the Health Protection Agency has reviewed actions taken in the Oxfordshire poultry farm outbreak. Based on the best evidence available from national flu experts, the Agency remains confident that all necessary steps are being taken...
Detection Of Mortality Clusters Associated With Highly Pathogenic Avian Influenza In Poultry: A Theoretical Analysis
Rapid detection of infectious disease outbreaks is often crucial for their effective control. One example is highly pathogenic avian influenza (HPAI) such as H5N1 in commercial poultry flocks. There is no quantitative data, however, on how quickly the effects of HPAI infection in poultry flocks can be...
Arbor Vita Rapid H5N1 Flu Diagnostic Presented At ICEID Meeting
Preliminary research from the Department of Respiratory Disease Research at the Naval Health Research Center (NHRC) suggests that a rapid antigen assay test developed by Arbor Vita Corporation (AVC) shows promise as a useful diagnostic for the detection of the avian influenza virus in humans. Researchers...